2010Zhongguo yaofangRequires access

Effect of Irbesartan and Losartan on Pharmacokinetics of Cyclosporin A in Rabbits

Liu Xin-hui

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the effect of irbesartan and losartan on pharmacokinetics of cyclosporin A(CsA)in rabbits. METHODS: 12 rabbits were randomly divided into two groups(n=6). In self-controlled study,plasma concentration of CsA in rabbits of two groups before and after treating with combination of irbesartan and losartan were determined and pharmacokinetics parameters were examined. RESULTS: After combination of irbesartan or losartan,the Cmax and AUC0~24 of CsA were significantly increased(P0.01),plasma clearance(CL)and apparent volume of distribution(Vd)significantly decreased(P0.05 or P 0.01). The remaining pharmacokinetic parameters had no significant changes. CONCLUSION: Irbesartan and losartan can increase blood concentrations of CsA and the combination use of the two drugs in clinic requires monitoring CsA blood concentration to ensure safe and effective treatment.

About this research paper

What this paper is about

OBJECTIVE:To study the effect of irbesartan and losartan on pharmacokinetics of cyclosporin A(CsA)in rabbits. METHODS: 12 rabbits were randomly divided into two groups(n=6). In self-controlled study,plasma concentration of CsA in rabbits of two groups before and after treating with combination of irbesartan and losartan were determined and pharmacokinetics parameters were examined. RESULTS: After combination of irbesartan or losartan,the Cmax and AUC0~24 of CsA were significantly increased(P0.01),plasma clearance(CL)and apparent volume of distribution(Vd)significantly decreased(P0.05 or P 0.01). The remaining pharmacokinetic parameters had no significant changes. CONCLUSION: Irbesartan and losartan can increase blood concentrations of CsA and the combination use of the two drugs in clinic requires monitoring CsA blood concentration to ensure safe and effective treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the effect of irbesartan and losartan on pharmacokinetics of cyclosporin A(CsA)in rabbits. METHODS: 12 rabbits were randomly divided into two groups(n=6). In self-controlled study,plasma concentration of CsA in rabbits of two groups before and after treating with combination of irbesartan and losartan were determined and pharmacokinetics parameters were examined. RESULTS: After combination of irbesartan or losartan,the Cmax and AUC0~24 of CsA were significantly increased(P0.01),plasma clearance(CL)and apparent volume of distribution(Vd)significantly decreased(P0.05 or P 0.01). The remaining pharmacokinetic parameters had no significant changes. CONCLUSION: Irbesartan and losartan can increase blood concentrations of CsA and the combination use of the two drugs in clinic requires monitoring CsA blood concentration to ensure safe and effective treatment.

Key concepts: Irbesartan, Losartan, Pharmacokinetics, Cmax, Pharmacology, Volume of distribution, Medicine, Losartan Potassium

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Irbesartan and Losartan on Pharmacokinetics of Cyclosporin A in Rabbits — Research Paper | ScholarLens